Legal analysis: Although oxytinib has entered the national medical insurance catalogue, it does not mean that everyone can be reimbursed if they buy it. Many times, for some special drugs, medical insurance reimbursement can only be carried out after the patient's condition meets certain requirements.

Legal basis: Article 17 of the Social Insurance Law of People's Republic of China (PRC), if an individual who participates in the basic old-age insurance dies due to illness or non-work, his survivors can receive funeral subsidies and pensions; Persons who have completely lost their ability to work due to illness or non-work-related disability before reaching the statutory retirement age can receive disability allowance. The required funds are paid from the basic old-age insurance fund.